Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: SeanS who wrote (1210)	3/3/1998 12:09:00 PM
From: DRRISK	Respond to of 2068

I am not convinced that we have broken 17 yet, I would call it a test for now I bought at the test, if we go lower next support is 16. This stock could also run unfettered to 21. It is way oversold at this point. IMHO DrRisk

To: SeanS who wrote (1210)	3/3/1998 12:12:00 PM
From: Raptor	Read Replies (1) \| Respond to of 2068

Just a few factoids to remember as the sand runs out of the hourglass: 1) Shareholders equity at 12/31/97 is $360 million. 2) Annualized premiums at 4th qtr run rate are $4.4 billion. 3) Premium to capital ratio before additional financing is 12:1. Outrageous. 4) NY State Attorney General is investigating company for fraud. 5) SEC is investigating for false statements and other such items. 6) TP financing is not in place until and unless an additional $350 million of debt financing is closed. 7) Computer systems are not yet able to tell the company what its real costs and revenues are supposed to be. 8) Public hearings to be held in NY City on the company's plan to raise individual rates by 50%. This should be good. It seems to me, the upside here is a prayer, a hope. The downside is receivership, a wipeout of common shareholders interests. I believe that this is how the endgame must play out for this, one of the greatest shell games/ frauds in modern corporate history. There will be books, case studies. This is not just another fallen angel. Oxford is in a special class of its own, in my view, but NOT for its franchise value. Good luck to all.